Pregnancy outcomes in women with autism: a nationwide population-based cohort study

Background The consequences of autism in pregnancy outcomes have not been explored before, although it is of crucial importance because of the frequent comorbidities and medication in this group of women. Objectives To estimate the risk of adverse pregnancy outcomes in women diagnosed with autism. Design Nationwide population-based cohort study. Setting Sweden. Participants Singleton births identified in the Swedish Medical Birth Registry, 2006–2014. A total of 2,198 births to women diagnosed with autism registered in the Swedish National Patient Registry were compared to 877,742 singleton births to women without such a diagnosis. Main outcome and measures Preterm delivery. Secondary measures were cesarean delivery (emergency and elective), Apgar score <7 at 5 minutes, small for gestational age, large for gestational age, stillbirth, gestational diabetes, and preeclampsia. ORs were calculated through logistic regression, adjusted for maternal age at delivery, maternal country of birth, smoking, maternal body mass index, parity, calendar year of birth, and psychotropic and antiepileptic medication during pregnancy. Results Women with autism were at increased risk of preterm birth (OR=1.30; 95% CI=1.10–1.54), especially medically indicated preterm birth (OR=1.41; 95% CI=1.08–1.82), but not with spontaneous preterm birth. Maternal autism was also associated with an increased risk of elective cesarean delivery (OR=1.44; 95% CI=1.25–1.66) and preeclampsia (OR=1.34; 95% CI=1.08–1.66), but not with emergency cesarean delivery, low Apgar score (<7), large for gestational age, gestational diabetes, and stillbirth. In women with medication during pregnancy, there was no increased risk of adverse pregnancy outcome except for induction of delivery (OR=1.33; 95% CI=1.14–1.55). Conclusion and relevance Maternal autism is associated with preterm birth, likely due to an increased frequency of medically indicated preterm births, but also with other adverse pregnancy outcomes, suggesting a need for extra surveillance during prenatal care.

[1]  Abdullah Al Mamun,et al.  Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis , 2018, The British Journal of Psychiatry.

[2]  Y. Hauck,et al.  The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness , 2017, The Australian & New Zealand journal of obstetrics & gynaecology.

[3]  Rahul Ganguly,et al.  Perinatal issues for women with high functioning autism spectrum disorder. , 2017, Women and birth : journal of the Australian College of Midwives.

[4]  D. Cawthorpe.  Comprehensive Description of Comorbidity for Autism Spectrum Disorder in a General Population. , 2017, The Permanente journal.

[5]  C. Giaquinto,et al.  Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation , 2016, PloS one.

[6]  P. Pennell.  Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts , 2016, Neurotherapeutics.

[7]  G. Adler,et al.  Immune related factors in pathogenesis of autism spectrum disorders. , 2016, European review for medical and pharmacological sciences.

[8]  N. Freemantle,et al.  Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. , 2016, Health technology assessment.

[9]  J. Bloch,et al.  Exploratory Study of Childbearing Experiences of Women With Asperger Syndrome. , 2016, Nursing for women's health.

[10]  Gun Peggy Knudsen,et al.  Ethical aspects of registry-based research in the Nordic countries , 2015, Clinical epidemiology.

[11]  L. Croen,et al.  A Study of Physician Knowledge and Experience with Autism in Adults in a Large Integrated Healthcare System , 2015, Journal of autism and developmental disorders.

[12]  S. Bookheimer,et al.  Neurobiology of Sensory Overresponsivity in Youth With Autism Spectrum Disorders. , 2015, JAMA psychiatry.

[13]  I. Hertz-Picciotto,et al.  Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. , 2015, JAMA pediatrics.

[14]  H. Lagercrantz,et al.  Survival and neonatal morbidity among extremely preterm born infants in relation to gestational age based on the last menstrual period or ultrasonographic examination , 2014, Journal of perinatal medicine.

[15]  Dulaney A Wilson,et al.  Epilepsy beyond seizure: A population-based study of comorbidities , 2014, Epilepsy Research.

[16]  W. Katon,et al.  A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. , 2014, General hospital psychiatry.

[17]  S. Gregory,et al.  Association of autism with induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education Research (1997-2007) databases. , 2013, JAMA pediatrics.

[18]  G. Koren,et al.  Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study , 2013, BMJ Open.

[19]  David W. Evans,et al.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence , 2013, The Lancet Neurology.

[20]  Dora M Raymaker,et al.  Comparison of Healthcare Experiences in Autistic and Non-Autistic Adults: A Cross-Sectional Online Survey Facilitated by an Academic-Community Partnership , 2013, Journal of General Internal Medicine.

[21]  C. Weinberg,et al.  On the pitfalls of adjusting for gestational age at birth. , 2011, American journal of epidemiology.

[22]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[23]  S. Nagarajan,et al.  Sensory Processing in Autism: A Review of Neurophysiologic Findings , 2011, Pediatric Research.

[24]  Suzanne McDermott,et al.  Pre-Eclampsia, Birth Weight, and Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.

[25]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[26]  S. Thornton,et al.  Preterm Birth: Causes, Consequences and Prevention , 2008 .

[27]  Anders Sundström,et al.  The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.

[28]  W. Stone,et al.  Sensory Experiences Questionnaire: discriminating sensory features in young children with autism, developmental delays, and typical development. , 2006, Journal of child psychology and psychiatry, and allied disciplines.

[29]  J. Moutquin.  Socio‐economic and psychosocial factors in the management and prevention of preterm labour , 2003, BJOG : an international journal of obstetrics and gynaecology.

[30]  B. Källén,et al.  The Swedish Medical Birth Register - a summary of content and quality , 2003 .

[31]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[32]  A. Selbing,et al.  Intrauterine growth curves based on ultrasonically estimated foetal weights , 1996, Acta paediatrica.